Search Count: 72
 |
Crystal Structure Of Sars-Cov-2 Mpro S10A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S10C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: DMS, EDO, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S113C In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro L115M In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S147A In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro S147N In Complex With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-12-10 Classification: VIRAL PROTEIN Ligands: V2M |
 |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Nirmatrelvir
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: 4WI, PEG |
 |
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: B1S |
 |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Pfizer Intravenous Compound Pf-00835231
Organism: Feline alphacoronavirus 1
Method: X-RAY DIFFRACTION Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: V2M, ACY, PG4, EDO, PEG |
 |
Co-Crystal Structure Of Feline Coronavirus Uu23 Main Protease With Ibuzatrelvir
Organism: Feline coronavirus uu23
Method: X-RAY DIFFRACTION Release Date: 2025-11-26 Classification: VIRAL PROTEIN Ligands: YDL |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166A With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: GOL, V2M |
 |
Crystal Structure Of Sars-Cov-2 Mpro Mutant L50F E166V With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2025-03-19 Classification: VIRAL PROTEIN, HYDROLASE/HYDROLASE INHIBITOR Ligands: DMS, V2M, CL |
 |
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION Resolution:2.08 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUY |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.77 Å Release Date: 2024-10-16 Classification: VIRAL PROTEIN Ligands: A1AUX |
 |
Co-Structure Of Main Protease Of Sars-Cov-2 (Covid-19) With Covalent Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.69 Å Release Date: 2024-10-16 Classification: HYDROLASE Ligands: A1AU4 |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant L141R With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN Ligands: DMS, V2M, NA |
 |
Crystal Structure Of Sars Cov-2 Mpro Mutant N142P With Pfizer Intravenous Inhibitor Pf-00835231
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.75 Å Release Date: 2024-02-07 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: V2M |